<scp>RNF122</scp> promotes glioblastoma growth via the <scp>JAK2</scp>/<scp>STAT3</scp>/c‐Myc signaling Axis
Our results revealed that RNF122 caused an aggressive phenotype to GBM and was a poor prognosticator; thus, targeting RNF122 may be effectual in GBM treatment.
Authors
- Kai Zhu (ORCID: https://orcid.org/0000-0002-9437-5254)
- Lin Li (ORCID: https://orcid.org/0000-0002-2158-7096)
- Kaming Xue
- Zhiyong Xiong
- Rong Fu (ORCID: https://orcid.org/0000-0002-7342-263X)
- Qingbao Xiao
Institutions
- Union Hospital (HK)
- Tongren Hospital (CN)
- Wuhan Union Hospital (CN)
- Wuhan Third Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/cns.70017
- Citations
- 3
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.85